Literature DB >> 32730826

Implementing the European Society of Cardiology 0-h/1-h algorithm in patients presenting very early after chest pain.

Masayuki Shiozaki1, Kenji Inoue2, Satoru Suwa3, Chien-Chang Lee4, Shuo-Ju Chiang5, Akihiro Sato1, Megumi Shimizu1, Kentaro Fukuda1, Masaru Hiki1, Naozumi Kubota1, Hiroshi Tamura1, Yasumasa Fujiwara1, Shohei Ouchi6, Tetsuro Miyazaki6, Yohei Hirano7, Hiroshi Tanaka7, Manabu Sugita8, Yuji Nakazato6, Masataka Sumiyoshi1, Hiroyuki Daida9.   

Abstract

BACKGROUND: The European Society of Cardiology (ESC) recommends a 0-h/1-h (0/1-h) algorithm to classify patients with suspected non-ST-segment elevation myocardial infarction (NSTEMI). However, reliable evidence about patients who present early after the onset of symptoms is limited, likely because high-sensitivity cardiac troponin (hs-cTn) values cannot increase sufficiently within that time. This study aimed to evaluate the outcomes in real-world situations that utilized the 0/1-h algorithm.
METHODS: In a prospective, international, multicenter cohort study that enrolled 1638 patients presenting with acute chest pain to the emergency department, we assessed the performance of the 0/1-h algorithm using hs-cTnT and the associated 30-day rates of major adverse cardiac events: death and acute myocardial infarction (AMI).
RESULTS: Among 1074 patients, the prevalence of AMI was 16.0%. An approximately 60.1% (n = 645) of patients visited the hospital within 3 h after onset of chest pain (less than 1 h; 18.2% [n = 196], less than 2 h; 27.5% [n = 295], and less than 3 h; 14.3% [n = 154]). Moreover, the prevalence rates of AMI were similar at all times (1 h, 16.8%; 1-2 h, 20.7%; 2-3 h, 18.2%; p = .5). According to the ESC 0/1-h algorithm, the distribution patterns of rule-out, observe, and rule-in groups were similar; however, none of the patients was diagnosed with AMI or cardiac death in the rule-out group.
CONCLUSION: This study revealed the applicability of the 0/1-h algorithm for the management of early presenters.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32730826     DOI: 10.1016/j.ijcard.2020.07.037

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  1 in total

1.  Clinical Evaluation of a New High-Sensitivity Cardiac Troponin I Assay for Diagnosis and Risk Assessment of Patients with Suspected Acute Myocardial Infarction.

Authors:  Masayuki Shiozaki; Kenji Inoue; Satoru Suwa; Chien-Chang Lee; Shuo-Ju Chiang; Akihiro Sato; Kentaro Fukuda; Naozumi Kubota; Hiroshi Tamura; Yasumasa Fujiwara; Kentaro Yamaguchi; Tomoaki Sato; Masataka Sumiyoshi; Hiroyuki Daida
Journal:  Cardiology       Date:  2021-01-18       Impact factor: 1.869

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.